Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

URGN holding history

UroGen Pharma Ltd. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

URGN overviewAll 13F holders of URGNFull Q2 2026 holdings

Shares (Q2 2026)
121,461
Value
$4.47M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of URGN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026121,461$4.47M<0.1%−38,197−23.9%ReducedHolders
Q1 2026159,658$2.87M<0.1%−75,382−32.1%ReducedHolders
Q4 2025235,040$5.50M<0.1%+54,580+30.2%AddedHolders
Q3 2025180,460$3.60M<0.1%−128,067−41.5%ReducedHolders
Q2 2025308,527$4.23M<0.1%−864,561−73.7%ReducedHolders
Q1 20251,173,088$13.0M<0.1%+250,390+27.1%AddedHolders
Q4 2024922,698$9.83M<0.1%+876,923+1,915.7%AddedHolders
Q3 202445,775$581.3K<0.1%+33,888+285.1%AddedHolders
Q2 202411,887$199.5K<0.1%−30,980−72.3%ReducedHolders
Q1 202442,867$643.0K<0.1%+17,798+71.0%AddedHolders
Q4 202325,069$376.0K<0.1%+5,850+30.4%AddedHolders
Q3 202319,219$269.3K<0.1%+5,111+36.2%AddedHolders
Q2 202314,108$146.0K<0.1%+14,108NewHolders
Q1 20230$00.0%−22,675−100.0%Sold outHolders
Q4 202222,675$201.1K<0.1%−20,914−48.0%ReducedHolders
Q3 202243,589$363.0K<0.1%+17,719+68.5%AddedHolders
Q2 202225,870$212.0K<0.1%−28,461−52.4%ReducedHolders
Q1 202254,331$473.0K<0.1%+6,675+14.0%AddedHolders
Q4 202147,656$453.0K<0.1%+46,345+3,535.1%AddedHolders
Q3 20211,311$22.0K<0.1%+411+45.7%AddedHolders
Q2 2021900$14.0K<0.1%−6,622−88.0%ReducedHolders
Q1 20217,522$147.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.